Thursday, January 24, 2008

Cardiovascular Risks Linked With Actos and Avandia.

Apprisal - Cardiovascular Risks Linked With Actos and Avandia.
The WARNINGS, PRECAUTIONS, and ADVERSE REACTIONS sections in the labelingfor Actos and Avandia were modified to more clearly describe thecardiovascular risks associated with the use of thiazolidinediones asmonotherapy and in compounding with other antidiabetic agents, particularlyinsulin.
This is a part of article Cardiovascular Risks Linked With Actos and Avandia. Taken from "Actos Pioglitazone" Information Blog

No comments: